The BOB.1/OBF
INTRODUCTION
The octamer motif is a critical regulatory element for B-cellspeci®c transcription (1, 2) . It is conserved in virtually all immunoglobulin heavy and light chain gene promoters as well as in several immunoglobulin enhancer elements. It is essential for the B-cell-speci®c promoter function and contributes to B-cell-speci®c enhancer activity. However, a variety of ubiquitously expressed genes, such as the histone H2B gene and most U sn RNA genes, require the octamer motif for ef®cient expression (3, 4) .
B cells express two octamer binding transcription factors, Oct1 and Oct2 (5) . Transcriptional activity conferred by the octamer motif requires additional coactivators (6±8). The BOB.1/OBF.1 (also named Bob.1, OBF-1 or OCA-B) coactivator interacts with either Oct1 or Oct2 and thereby activates transcription from promoter-proximal positions (9± 12). Activity from distal enhancer positions speci®cally requires the presence of Oct2 and a further still unknown Bcell-restricted coactivator (8, 13) . BOB.1/OBF.1 itself does not bind to the octamer motif with high af®nity, but rather is recruited into the active transcription complexes via protein± protein interactions with the Oct proteins. It does, however, increase the selectivity of the ternary complexes for a subset of octamer motifs by making contacts with the major groove of DNA within the octamer motif and with the POU-speci®c domain and the POU homeodomain (14±17). Furthermore, by contacting both POU subdomains simultaneously, BOB.1/ OBF.1 can act as a molecular clamp that holds together these subdomains on DNA (18) . A BOB.1/OBF.1 protein isoform bearing an N-terminal extension is myristylated in vivo and localized in the membrane fraction. The exact function of this BOB.1/OBF.1 isoform is not known (19) .
BOB.1/OBF.1 is expressed at all stages of B-cell development. Expression levels are highest in germinal center B cells and can be induced in resting B cells by appropriate stimulation (20, 21) . In B cells, expression of BOB.1/OBF.1 is not only regulated at the level of transcription but also at the level of protein stability (22, 23) . Furthermore, expression and function of BOB.1/OBF.1 can be induced by co-stimulation of T lymphocytes (24) .
Inactivation of the gene coding for the BOB.1/OBF.1 coactivator affects several stages of B-cell development. In bone marrow a reduction of transitional B cells is observed (25) . Additionally, numbers of B cells in the periphery, as well as of recirculating B cells in the bone marrow, are reduced. The most striking characteristic of BOB.1/OBF.1-de®cient mice is the complete failure to form germinal centers in spleens and lymph nodes (26±28). Notably, expression of the immunoglobulin heavy and light chain genes is not impaired in B cells from BOB.1/OBF.1-de®cient mice. As a consequence, normal levels of IgM are produced, whereas the amounts of switched immunoglobulin isotypes are strongly reduced. In addition, development of marginal zone B cells is disturbed (29) and the number of apoptotic B cells is increased (25) . A bcl2 transgene can rescue all aspects of early B-cell development in BOB.1/OBF.1-de®cient mice. However, terminal differentiation and function is still defective (30) . Surprisingly, in mice simultaneously de®cient for BOB.1/ OBF.1 and Oct2, B cells develop up to the IgM-positive B-cell stage and immunoglobulin gene transcription was not affected (31) .
So far, only a few genes have been identi®ed which are regulated by BOB.1/OBF.1. In B cells the expression of the BLR1 gene (32) was shown to be regulated cooperatively by the transcription factors NF-kB and Oct2, as well as the cofactor BOB.1/OBF.1. The CCR-5 gene expression (33) was shown to be controlled by BOB.1/OBF.1 and Oct2 in T cells. Expression of both of these genes was only partially affected by the lack of BOB.1/OBF.1. We recently searched for BOB.1/OBF.1 target genes by Chip-based expression pro®ling and identi®ed a set of genes both induced and repressed by BOB.1/OBF.1 (34) . The products of these genes are involved in various aspects of B-cell physiology, such as cellular metabolism, cell adhesion and differentiation. In the present study, we used a parallel approach to search for BOB.1/OBF.1 target genes, employing the cDNA representational difference analysis (RDA) method (35) . We identi®ed a gene coding for the myosin light chain 1 atrial (MLC1A) isoform, which was previously described as being speci®cally expressed in the early development of mouse muscle cells in the embryo (MLC1emb), and in the adult mouse in heart atria (MLC1A) (36±39). Here, we show that MLC1A is expressed in murine pre-B cell lines as well as in primary pre-B cells in a BOB.1/ OBF.1-dependent manner. In B cells, MLC1A transcripts are expressed using an alternative 5¢UTR as compared with the one utilized in mouse muscle cells.
MATERIALS AND METHODS

Cell culture and transfection
The BOB.1/OBF.1-de®cient Abelson virus-transformed pre-B cells [MB10-mock and MB10-BobER stable cell lines (40) ] were kept in Iscoves modi®ed Dulbecco's medium (IMDM; Life Technologies, Inc.), supplemented with 10% fetal bovine serum, penicillin/streptomycin, L-glutamate and 50 mM b-mercaptoethanol and grown at 37°C and 10% CO 2 . All other cell lines were kept in Dulbecco's modi®ed Eagle's medium/glutamax (DMEM; Life Technologies, Inc.) supplemented with 10% fetal bovine serum, penicillin/streptomycin and 50 mM b-mercaptoethanol and grown at 37°C and 5% CO 2 . For hydroxytamoxifen (OHT) induction experiments, cells were treated with 200 nM OHT (BioTrend Chemikalien GmbH) and, as indicated, pre-incubated for 30 min with 1 mg/ml cycloheximide (CHX). NIH/3T3 cells were transiently transfected by electroporation (450 V, 250 mF in PBS), pRL-CMV (Promega) was cotransfected in all experiments and used for normalization of different transfection ef®ciencies in the individual experiments.
Plasmids
Different MLC1A promoter constructs (±630, ±3000) were recloned from the originally MLC1A-CAT constructs [kindly provided by M. Buckingham (41) ] or ampli®ed by PCR (±680) and cloned into the pTKL/2 vector containing the HSVthymidine kinase promoter (±105 to +52) from the pBLCAT2 in front of the ®re¯y luciferase coding region. The HSVthymidine kinase promoter was excised by a restriction endonuclease digest and replaced by the MLC1A promoter sequences. The wild-type BOB.1/OBF.1 cDNA was cloned into the expression vector pCDNA3. For luciferase reporter assays the octamer-dependent reporter plasmid mET1 was used as an internal control (40) .
cDNA RDA Poly(A) + RNA was prepared from the indicated cell lines as described (40) . cDNA was prepared using the cDNA synthesis kit (Roche Diagnostics, Mannheim, Germany). The cDNA RDA protocol was performed exactly as described by Hubank and Schatz (35) . MB10-mock cDNA was used as driver, MB10-BobER cDNA as tester. For the three subsequent rounds of hybridizations the tester/driver ratios were 1:100, 1:800, 1: 500 000. The difference product III (DPIII) was DpnII digested, cloned into BamHI cut pBluescript and 160 randomly picked cDNAs were sequenced using the T7 primer.
RACE protocol
5¢ Rapid ampli®cation of cDNA ends (RACE) was performed using the RACE-kit (Life Technologies, Inc.) according to the instructions of the manufacturer. The following primers were used: myGSP1 (cca ttg gca tcc tcc), myGSP2 (tcc acc tct gcc tcg ct) and myGSP3 (ccg cag ccc ctc cac gaa g).
RT±PCR analysis
CD38-negative and -positive cells from human tonsils were isolated as described before (21, 42) . Total RNA of the respective cells or cell lines was used to prepare cDNA using SuperscriptII or M-MLV reverse transcriptase (Life Technologies, Inc.; Gibco). The cDNAs were used to analyze the expression of different MLC1A isoforms. PCR was performed as follows: 3 min at 94°C, 30 cycles of 30 s at 94°C, 60 s at 60°C, 90 s at 72°C. PCR products were analyzed on a 1.2% agarose gel. The following primers were used: MLC1A-3.1 (tgc tcc acc tct gcc tcg ctc atc), MLC1A-5.1 (gcc aga acc cca cca acg cag ag), MLC1A-5.2 (ccc acc tcc act gga gag cc), MLC1A-5.3 (cct ctg tgg ggg ctc cta ccc), MLC1A-5.4 (cga gcc acc tct cct cct ttg g), MLC1A-5.5 (ccc acc cct ctc tgg gtt tcc). For the simultaneous detection of murine and human MLC1A expression, the following primers were used: m/ hMLC1A forward, gga gag atg aag atc acc tac gg; m/hMLC1A reverse, ggt gcc ctg ctc ctt gtt gc.
Northern blot analysis
Preparation and analysis of total cytoplasmic RNA, poly(A) + RNA and northern blots were performed as described (40) . For analysis of MLC1A expression an MLC1A cDNA fragment was ampli®ed using the MLC1A-5.1 and MLC1A-3.1 primers.
RESULTS AND DISCUSSION
In order to identify BOB.1/OBF.1-dependent target genes in BOB.1/OBF.1-de®cient B cells, we used a previously described Abelson virus-transformed pre-B cell line established from the bone marrow of BOB.1/OBF.1-de®cient mice. In addition, they were transduced with a retrovirus, which resulted in the expression of an inducible BobER fusion protein (40) . In this cell line (MB10-BobER), octamerdependent synthetic promoter and immunoglobulin promoter/enhancer driven reporter constructs were inactive, unless the activity of the BobER protein was induced by the hormone OHT (40) . The use of this system allows us to examine B cells at the same stage of differentiation. Using this approach, differential gene expression should be caused by the transcriptional activity of the BOB.1/OBF.1 protein.
The MB10-BobER cells and, as control, the MB10-mock cell line, which was infected with the empty expression vector, were induced with OHT to avoid potential side effects of OHT. RNA was prepared from the induced cell lines and a cDNA RDA screen was performed (35) . The MB10-BobER cDNA was used as tester, the MB10-mock cDNA as driver. After three rounds of hybridization/ampli®cation the resulting cDNAs (DPIII) were cloned into the pBluescript vector and subsequently 160 clones were sequenced.
Among these clones, we frequently found estrogen receptor sequences (~50%), con®rming that the cDNA RDA protocol enriched differentially expressed clones. Most of the remaining clones were single cDNA isolates and appeared not to be regulated by BOB.1/OBF.1 (data not shown). The cDNA identi®ed most frequently (12 times) beside the estrogen receptor sequences was derived from the MLC1A gene.
The MLC1A gene was originally identi®ed as an essential myosin light chain, speci®cally expressed in the murine heart atria (MLC1A,`atrial' isoform). Additionally, it was described as the ®rst myosin light chain during early embryonic development in embryonic skeletal muscle, therefore, also designated as MLC1emb (`embryonic' isoform) (36±38). The MLC1A gene was differentially expressed as con®rmed by northern blot (Fig. 1A) . In addition to an unspeci®c band already present in the mock-infected cell line (see below), a second, more slowly migrating band, was observed in cells expressing the active BobER fusion protein.
In addition, several other cDNA clones were isolated repeatedly but less abundant, like alpha enolase, translation initiation factor 4E, complement protein C7 and several dehydrogenase motives. Notably, the transcripts for aldehyde dehydrogenase-2 like, the aldoketoreductase AKR1C13 and several other genes had been identi®ed as BOB.1/OBF.1 regulated genes using a recently applied gene expression pro®ling approach and have been already described (34) . Here we will focus on the analysis of the MLC1A gene.
We analyzed the in¯uence of the hormone OHT on MLC1A expression in BobER-expressing cells. RNA was prepared from either uninfected MB10 cells, mock-infected MB10 cells or MB10 cells expressing the BobER allele (MB10-BobER), treated with OHT or left uninduced, and analyzed with the MLC1A-speci®c probe in northern blot experiments (Fig. 1B) . As a control, RNA from PD31, an Abelson virus-transformed wild-type pre-B cell line, was included in this study. In all analyzed samples, the faster migrating non-speci®c band was visible, albeit at somewhat variable levels. Additionally, the MLC1A-speci®c (slower) band could be detected in the case of BOB.1/OBF.1-expressing PD31 cells and in OHT-treated MB10-BobER cells. In the case of PD31 cells, this expression was OHT independent as expected, whereas in BobERexpressing cells MB10-BobER, the expression of this additional band was regulated by treatment with OHT. Identical results were obtained analysing a second BobER-expressing cell clone (data not shown). To exclude a non-physiological expression of MLC1A in the Abelson virus-transformed pre-B cell lines we next analyzed primary mouse pre-B cells cultured in the presence of the cytokine IL-7 on a stromal cell layer (Fig. 1C) . Northern blot analysis revealed a strong MLC1A expression in wild-type pre-B cells. Notably, MLC1A was also detected in Oct2-de®cient pre-B cells, whereas in BOB.1/ OBF.1-de®cient B cells no MLC1A was detectable con®rming the BOB.1/OBF.1 dependence of its expression.
Since we always observed two bands in the BOB.1/OBF.1-expressing pre-B cells we asked if both of these bands are MLC1A speci®c. MLC1A expression in adult mice was reported to be restricted to the atrium (36±39) and should not be expressed in other tissues, for example, in ®broblasts. When we analyzed MLC1A expression in NIH/3T3 cells, in 10T ®broblast cells and in ST2 stroma cells by northern blots, only the slower migrating band could be detected (data not shown). These data indicate that the lower band is rather an unspeci®c hybridization than an MLC1A-speci®c signal. To corroborate this conclusion we used MLC1A gene-speci®c primers to analyze MLC1A transcripts by RT±PCR. At high numbers of PCR cycles we observed low MLC1A expression in MB10-mock cells and a massive increase of MLC1A in MB10-BobER cells. However, no PCR product could be detected in the ®broblast cell line NIH/3T3 (Fig. 1D) . The speci®city of the RT±PCR was veri®ed by sequencing the PCR products and by performing RT±PCR with mouse atria RNA that gave a product of the same size (data not shown). Therefore, we conclude that the upper band observed in northern blot experiments corresponds speci®cally to MLC1A, whereas the lower band results from an unspeci®c hybridization.
As mentioned above, MLC1A, so far, was described as being expressed speci®cally in atria but not in other adult tissues. We were interested to determine whether MLC1A was expressed throughout the B-cell lineage and/or even in other hematopoietic cells. Therefore, we performed northern blot analysis with several additional B cell lines representing different stages of B-cell development. However, whereas the MLC1A band was present in pre-B cells, no expression was seen in cell lines representing immature B cells (WEHI 231), plasma cell stage (S194), or in T cells irrespective of whether they express BOB.1/OBF.1 (EL4) or not (BW 5147) (data not shown). In addition, we analyzed several other mature B and plasma cell lines but could not detect MLC1A expression. Furthermore, analysing lymphocytes derived from total spleen of wild-type or BOB.1/OBF.1-de®cient mice by RT±PCR no MLC1A expression could be detected even in wild-type splenocytes. In parallel, mouse atria were analyzed where MLC1A expression was observed (Fig. 1E) . Since the expression level of BOB.1/OBF.1 is the highest in germinal centers, we asked whether MLC1A is also upregulated in mature IgM low IgD high CD38 + primary human germinal center B cells. Using primers speci®c for the mouse, as well as for the human, MLC1A gene, RT±PCRs were performed with cDNAs from mouse atria as a positive control or from human CD38 + germinal center and CD38 ± non-germinal center mature B cells (Fig. 1F) . No MLC1A expression could be detected either in mature germinal center cells or in nongerminal center B cells and other mature B cells. Therefore, MLC1A expression seems to be restricted to the pre-B-cell stage. This observation is not surprising, since BOB.1/OBF.1 was shown to be required at several stages of B-cell development including the pre-B-cell stage. Additionally, the target gene screen was performed using pre-B cells. Thus, identi®ed BOB.1/OBF.1-dependent genes might be expressed and regulated only at this stage of B-cell development. This observation is reminiscent of the Oct2 target gene CRISP-3, which is expressed in pre-B cells and has not been found at later developmental B-cell stages (43).
MLC1A was described as being expressed in mouse atria and in the mouse skeletal muscle cell line C2C12. We wanted to compare the expression levels of MLC1A in pre-B cells with that in muscle cells. Northern blot experiments indeed con®rmed a very strong MLC1A expression in mouse muscle cells, especially in the atria (Fig. 2A) . This muscle-speci®c expression (in atrium and C2C12 cells) was signi®cantly stronger than the MLC1A expression level found in PD31 cells. Interestingly, when we compared the sizes of MLC1A-speci®c bands it became clear that the pre-B-cell-speci®c band was slightly larger than that in the muscle cells. We reasoned that MLC1A might be alternatively spliced in mouse pre-B cells. In human skeletal muscle cells, different 5¢UTR and 3¢UTRs of the MLC1A gene are expressed (44, 45) , whereas in the mouse, so far, only one 5¢UTR has been described. We performed 5¢-RACE with RNA from the MB10-BobER cell line induced with OHT. A dominant 5¢UTR from pre-B cells was identi®ed, which we named distal 5¢UTR since it results from an alternative upstream promoter and consequently from a splice process within the MLC1A 5¢UTR. The previously described 5¢UTR from mouse muscle cells was named proximal 5¢UTR (sequences of both 5¢UTRs are compared in Fig. 2B) . Therefore, the situation in mouse pre-B cells resembles that in human muscle cells, where distinct MLC1A and MLC1emb mRNAs are expressed differing in their 5¢UTRs (44, 45) . The function of the alternative transcript in humans is still unclear.
In order to analyze if both 5¢UTRs are expressed in mouse B cells, we prepared primer pairs in order to distinguish the different 5¢UTRs by RT±PCR (Fig. 3A) . Using the primer 5.1 (located in MLC1A exon 3) or 5.2 (located nearby the translation initiation signal), an MLC1A-speci®c PCR product should be observed in all cases, independent of the speci®c 5¢UTRs used. The 5.3 primer was a negative control since it is located in the region between distal and proximal promoters that is spliced out. Consequently, no PCR product should be observed. Using the primer 5.5 or 5.4 we can distinguish which 5¢UTR was used. As expected, the primers 5.1 (Fig. 1D ) and 5.2 (Fig. 3B) We then addressed the question whether regulation of MLC1A expression by BOB.1/OBF.1 is direct or involves an intermediate. We generated luciferase reporter constructs, differing in the length of the MLC1A promoter ±630, ±680 or ±3000 bp. The activity of all these reporters was increased by BOB.1/OBF.1 cotransfection in NIH/3T3 cells (Fig. 4A) . The highest induced activity was found in the case of the shortest 630 bp promoter, which is consistent with the earlier observation in muscle cells that 630 bp of the mouse MLC1A promoter are suf®cient to achieve a regulated expression of the gene (41) . However, the basal activity of the ±630 bp promoter was also higher compared with the longer promoter constructs. Determining the absolute induction of analyzed promoters by BOB.1/OBF.1, all constructs were induced equally~2±3-fold. Surprisingly, when the activity of these constructs was analyzed in MB10-BobER cells, no OHT induction of luciferase activity could be observed analyzing cells 24 h after transfection, while some induction of luciferase activity was observed upon longer incubation (data not shown). This result suggested that the activation of MLC1A gene transcription by BOB.1/OBF.1 might be indirect. Since BobER cells originally used for the presented RDA were induced with OHT for 20 h, we cannot exclude an indirect regulation of identi®ed genes by BOB.1/ OBF.1. Recently, two E-box motives were shown to be critically involved in the regulation of the MLC1A promoter, binding MyoD/E12 and myogenin/E12 heterodimer (41, 46) . Importantly, the known MLC1A promoter sequences do not contain recognizable octamer motifs which could mediate the regulation via BOB.1/OBF.1.
To address this issue, MB10-BobER cells were preincubated with the protein synthesis inhibitor CHX and induced for 12 h with OHT. Northern blot analyses revealed that CHX prevents the OHT-mediated induction of MLC1A by BOB.1/OBF.1 (Fig. 4B) , indicating that MLC1A indeed is indirectly regulated by BOB.1/OBF.1.
The actin±myosin complex is the main contractile component of the muscle sarcomers. Furthermore, actin and myosin undergo reorganization in cultured mammalian nonmuscle cells in response to cellular signals during various motile processes in cells, such as chemotaxis, phagocytosis, capping of surface receptors, vesicle transport and cytokinesis (47±50).
Many functions of myosins in non-muscle cells have been described, such as cytoskeletal dynamics, which in turn are essential for cell migration and motility. Immune cells are characterized by cellular movement between compartments. Immature (transitional) B cells emerge from the bone marrow to the periphery and migrate into speci®c microenvironments of peripheral secondary lymphoid tissues, such as spleen and lymph nodes. Although the physical sites of B-cell precursor development and differentiation in the bone marrow remain poorly de®ned, it is likely that the actin±myosin complex is also essential for B-cell motility of earlier developmental stages, e.g. to build contacts with the stromal layer, important for progenitor B cells. This hypothesis is supported by recent ®ndings demonstrating the important role of cytoskeleton reorganization of hematopoietic stem/progenitor cells. These processes affect adhesion and mobilization from the medullary cavity into the blood circulation and migration into lymph nodes or sites of in¯ammation (51, 52) . Additionally, it was shown that the cytoskeletal organization that contributes to the shape of hematopoietic cells in¯uences the transduction of growth signals through a number of externally activating signaling pathways (53) . B cells de®cient for BOB.1/OBF.1 have several defects in early development in the bone marrow and cannot properly develop into transitional B cells (25) . Taking together, the BOB.1/OBF.1-dependent expression of an essential myosin light chain in pre-B cells could be a novel mechanism to achieve a regulation of potential functions of actin±myosin motility in pre-B cells, essential for development and function. . Additionally, as an internal control, the BOB.1/OBF.1-dependent mET1 promoter was analyzed. The value of the mET1 promoter vector was set to one. The fold induction was determined. (B) Northern blot analysis using an MLC1A-speci®c probe and 10 mg of total RNA of MB10-BobER pre-B cell line. Cells were induced with OHT (200 nM) for the indicated time or pre-treated with CHX (1 mg/ml), as indicated, for 30 min, RNA was prepared and subsequently subjected to northern blot analyses.
